Effect of Donepezil on Cognitive Impairment, Quality of Life, and Depression in Multiple Sclerosis Patients: A Randomized Clinical Trial
Conclusions:Donepezil could effectively improve cognitive impairment in MS patients. Also, its positive effect on QOL and depression could result in a smaller number of interventions in this group of patients.Keywords:Cognitive dysfunction, depression, donepezil, multiple sclerosis, quality of life
Source: International Journal of Preventive Medicine - Category: International Medicine & Public Health Source Type: research
More News: Clinical Trials | Depression | Donepezil | International Medicine & Public Health | Men | Multiple Sclerosis | Statistics | Study